FederalDC
Posted
Oct 18, 2024
Oct 18, 2028
Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partners
The GUIDE program uses computational and experimental methods, including advanced simulation and machine learning, to accelerate medical countermeasure development. It seeks to improve discovery and design of biological products and small-molecule drugs while optimizing safety, efficacy, manufacturability, and other development attributes. This special notice invites qualified entities to request participation through a Participant Basic Agreement and demonstrate relevant expertise; it is not a grant program, and the notice makes no commitment to award.
